Standard Operating Procedure for Regulatory Milestone Tracking Across Global Markets
| Department | Regulatory Affairs |
| SOP No. | RA/2026/607 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 07/04/2026 |
| Effective Date | 07/04/2026 |
| Review Date | 07/04/2028 |
Purpose
This SOP establishes the standardized process for tracking regulatory milestones for pharmaceutical products and submissions across multiple global markets. It ensures timely monitoring, documentation, and communication of key regulatory activities to facilitate compliance with regional requirements and supports effective regulatory strategy execution. This control objective minimizes risks associated with delayed submissions, missed deadlines, or non-compliance, thereby safeguarding product launch timelines and regulatory standing.
Scope
This procedure applies to regulatory affairs personnel responsible for managing and monitoring regulatory milestones related to dossier submissions, approvals, renewals, variations, inspections, and reporting obligations for all dosage forms and pharmaceutical products in global markets where the organization operates. It encompasses electronic and manual tracking systems, milestone documentation, and reporting tools. This SOP does not cover detailed dossier preparation, clinical trial management, or pharmacovigilance activities.
Responsibilities
The following roles are responsible for executing, supervising, verifying, reviewing, and documenting this procedure:
- Regulatory Affairs Specialists – Track and update milestone progress, maintain records.
- Regulatory Affairs Managers – Review milestone status, coordinate communication with cross-functional teams.
- Quality Assurance – Verify compliance and audit milestone tracking process.
- Regulatory Operations Coordinator – Maintain milestone tracking tools and escalate issues.
- Document Control – Manage related procedural and milestone documentation.
Accountability
The Head of Regulatory Affairs is accountable for ensuring overall implementation, compliance, periodic review, escalation of issues related to milestone tracking, and effectiveness of this SOP. They are responsible for authorizing procedural updates and ensuring adequate training on this SOP within the department.
Procedure
1. Preparation and Prerequisites
Regulatory Affairs (RA) personnel shall ensure access to updated regulatory calendars, registration dossiers, communication records, and milestone tracking systems prior to initiating tracking activities. Confirm the list of products, markets, and relevant submissions for monitoring each period.
2. Establishing Milestones
Define and document key regulatory milestones relevant to each submission or product, including but not limited to submission dates, queries, response deadlines, approval dates, renewal timelines, and inspection schedules. Align milestones according to regulatory guidance and internal project plans.
3. Data Entry and Tracking
Input milestone data into a centralized approved tracking system or logbook immediately following milestone initiation (e.g., submission date). Update progress status routinely, reflecting any correspondence, changes, or delays. Ensure system integrity through password controls and role-based access management.
4. In-Process Controls and Monitoring
Regularly monitor milestone adherence through weekly or monthly reviews. Identify deviations such as missed deadlines or incomplete responses. Escalate such deviations timely to the Regulatory Operations Coordinator and RA management for corrective action.
5. Verification and Approvals
RA Managers shall verify milestone data accuracy through periodic audits or reviews and approve milestone completion status. Any adjustments must be documented with reason and approval details.
6. Documentation and Record Retention
All milestone tracking data, supporting documents, correspondence, and audit findings shall be documented systematically and retained according to internal documentation control policies and applicable regulatory retention requirements.
7. Closure and Reporting
Upon successful completion of all regulatory activities associated with a milestone, formally close the milestone in the tracking system. Generate periodic milestone status reports for management review and compliance audits. Submit reports as per organizational procedures.
8. Training and Continuous Improvement
Ensure all responsible personnel are trained on this SOP and milestone tracking tools prior to execution. Review and update this SOP biennially or as applicable based on compliance feedback, regulatory changes, or process improvements.
Abbreviations
RA – Regulatory Affairs
SOP – Standard Operating Procedure
GMP – Good Manufacturing Practice
QA – Quality Assurance
CSV – Computer System Validation
Documents
- Regulatory Milestone Tracking Log (Annexure-1)
- Milestone Status Review Report (Annexure-2)
- Deviation and Escalation Form for Milestone Delays (Annexure-3)
References
ICH Q10 – Pharmaceutical Quality System
FDA Guidance for Industry on Submission Timelines
EU GMP Annex 11 – Computerized Systems
Internal Quality Manual – Document Control and Records Management
Local Regulatory Requirements for Product Registration and Reporting
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Regulatory Milestone Tracking Log
Purpose: To systematically record and monitor all regulatory milestones for products across global markets.
| Product Name | Country/Market | Submission Type | Milestone Description | Planned Date | Actual Date | Status | Comments |
|---|---|---|---|---|---|---|---|
| Product A | USA | New Drug Application | Submission | 15/04/2026 | 14/04/2026 | Completed | Submitted ahead of schedule |
| Product B | EU | Variation | Response to Query | 20/05/2026 | Pending | Awaiting documents from QA | |
| Product C | Japan | Renewal | Approval | 30/06/2026 | In Progress | On track |
Annexure-2: Milestone Status Review Report
Purpose: To summarize milestone tracking statuses and deviations for management review.
| Review Period | Total Milestones | Completed | On Schedule | Delayed | Corrective Actions |
|---|---|---|---|---|---|
| 01/03/2026 – 31/03/2026 | 25 | 20 | 4 | 1 | Escalation raised, documents delayed |
| 01/04/2026 – 30/04/2026 | 30 | 22 | 7 | 1 | Additional training scheduled |
Annexure-3: Deviation and Escalation Form for Milestone Delays
Purpose: To document deviation from scheduled milestones and record escalation details for corrective follow-up.
| Deviation ID | DEV-RA-2026-001 |
| Date Reported | 18/04/2026 |
| Product | Product B |
| Market | EU |
| Milestone Description | Response to Query |
| Scheduled Date | 20/05/2026 |
| Deviation Details | Delay in receiving QA confirmation causing potential milestone slippage. |
| Escalated To | Regulatory Affairs Manager |
| Corrective Action Plan | QA to expedite documentation; weekly follow-up initiated. |
| Follow-up Date | 27/04/2026 |
| Closure Date | |
| Remarks |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 07/04/2026 | 1.0 | Initial issue | New SOP creation |